Specialising in electronics and medical devices, Kevin Cordina heads up the patent prosecution practice at Simmons & Simmons, which boasts offices in the UK, Amsterdam, and Munich. The team expertly undertakes transactional work and litigation, including in the UPC, and European patent opposition matters are another key focus of the group. The team is also home to Frederick Nicolle, who is particularly active in the pharmaceutical and chemistry industries.
L’éditorial du Legal 500
- Profil
- Réseaux sociaux
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The S&S team has an incredible depth of knowledge in a wide variety of subjects and industrial pockets. We were very impressed with the deep understanding and the pragmatic thinking, taking commercial aspects into account well.’
'Kevin Cordina has a calm and understanding personality with depth of knowledge and passion to advise. He keeps commercial aspects in focus rather than an academic exercise.'
Clients clés
- Danaher
- Solventum
- Apple
- Enoda
- Acerus Pharmaceuticals
- Natura Cosmeticos
- Haemochromatosis UK
- Celanese
- Axovia Therapeutics
- Okipa
Points forts
- Advising Danaher Corporation on all of its group companies and patent matters.
- Advising Okipa on a wide range of commercial IP and patent issues, including leading multiple international ownership disputes and building a patent portfolio for its innovative products.
- Representing Solventum in European patent prosecution and opposition matters, as well as a full range of commercial IP issues.
Avocats
Responsable de la pratique
Kevin Cordina
Autres avocats clés
Laurence Lai; Frederick Nicolle